Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1625 of 3284 entries
View as:

Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06727227 Org: User:
Start: 01/29/25 End: 03/31/27 Due: 03/31/28

Chronic Kidney Disease Registry Platform Study

Phase: N/A Priority: Normal
NCT ID: NCT06117852 Org: User:
Start: 11/28/23 End: 08/31/27 Due: 08/31/28

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05457257 Org: User:
Start: 07/29/22 End: 09/30/25 Due: 09/30/26

Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific

Phase: N/A Priority: Normal
NCT ID: NCT02442349 Org: User:
Start: 06/22/15 End: 12/31/25 Due: 12/31/26

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT04121910 Org: User:
Start: 11/07/19 End: 01/12/20 Due: 01/12/21

A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab

Phase: N/A Priority: Normal
NCT ID: NCT06042049 Org: User:
Start: 07/27/23 End: 08/15/25 Due: 08/15/26

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02296125 Org: User:
Start: 12/03/14 End: 12/31/25 Due: 12/31/26

ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00252798 Org: User:
Start: 07/31/02 End: 10/31/05 Due: 10/31/06

Study of the Clinical Management of Bipolar Disease

Phase: N/A Priority: Normal
NCT ID: NCT01062607 Org: User:
Start: 04/30/10 End: 06/30/11 Due: 06/30/12

AZD5985 Single Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00967356 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10

Quetiapine in Postpartum Depression

Phase: N/A Priority: Normal
NCT ID: NCT00681668 Org: User:
Start: 08/31/07 End: 10/31/08 Due: 10/31/09

Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00785057 Org: User:
Start: 11/30/08 End: 12/31/08 Due: 12/31/09

Iressa 2nd Line Phase III Study in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00252707 Org: User:
Start: 09/30/03 End: 11/30/06 Due: 11/30/07

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02153398 Org: User:
Start: 06/30/14 End: 04/30/16 Due: 04/30/17

Prevention of Asthma Relapse After Discharge From Emergency

Phase: N/A Priority: Normal
NCT ID: NCT00326053 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)

Phase: N/A Priority: Normal
NCT ID: NCT00163332 Org: User:
Start: 03/31/03 End: - Due: -

Pharmacokinetics of Cotadutide in Participants With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05517226 Org: User:
Start: 09/06/22 End: 02/27/23 Due: 02/27/24

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00077025 Org: User:
Start: 01/31/04 End: 05/31/13 Due: 05/31/14

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00935025 Org: User:
Start: 07/31/09 End: 11/30/09 Due: 11/30/10

IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00242749 Org: User:
Start: 12/31/02 End: 07/31/07 Due: 07/31/08

Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05250011 Org: User:
Start: 04/19/22 End: 04/15/24 Due: 04/15/25

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Phase: N/A Priority: Normal
NCT ID: NCT01293435 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01257971 Org: User:
Start: 01/31/11 End: 10/31/11 Due: 10/31/12

A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Phase: N/A Priority: Normal
NCT ID: NCT06942910 Org: User:
Start: 05/07/25 End: 07/31/26 Due: 07/31/27

Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00873249 Org: User:
Start: 04/30/09 End: 03/31/10 Due: 03/31/11